These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 17178785)

  • 41. Alveolar response to Pseudomonas aeruginosa: role of the type III secretion system.
    Ader F; Le Berre R; Faure K; Gosset P; Epaulard O; Toussaint B; Polack B; Nowak E; Viget NB; Kipnis E; Guery BP
    Infect Immun; 2005 Jul; 73(7):4263-71. PubMed ID: 15972518
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nitrite reductase NirS is required for type III secretion system expression and virulence in the human monocyte cell line THP-1 by Pseudomonas aeruginosa.
    Van Alst NE; Wellington M; Clark VL; Haidaris CG; Iglewski BH
    Infect Immun; 2009 Oct; 77(10):4446-54. PubMed ID: 19651860
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel phosphatidylinositol 4,5-bisphosphate binding domain mediates plasma membrane localization of ExoU and other patatin-like phospholipases.
    Tyson GH; Halavaty AS; Kim H; Geissler B; Agard M; Satchell KJ; Cho W; Anderson WF; Hauser AR
    J Biol Chem; 2015 Jan; 290(5):2919-37. PubMed ID: 25505182
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pseudomonas aeruginosa Type III Secretory Toxin ExoU and Its Predicted Homologs.
    Sawa T; Hamaoka S; Kinoshita M; Kainuma A; Naito Y; Akiyama K; Kato H
    Toxins (Basel); 2016 Oct; 8(11):. PubMed ID: 27792159
    [No Abstract]   [Full Text] [Related]  

  • 45. Type III secretion-dependent modulation of innate immunity as one of multiple factors regulated by Pseudomonas aeruginosa RetS.
    Zolfaghar I; Evans DJ; Ronaghi R; Fleiszig SM
    Infect Immun; 2006 Jul; 74(7):3880-9. PubMed ID: 16790760
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Rickettsia prowazekii ExoU homologue possesses phospholipase A1 (PLA1), PLA2, and lyso-PLA2 activities and can function in the absence of any eukaryotic cofactors in vitro.
    Housley NA; Winkler HH; Audia JP
    J Bacteriol; 2011 Sep; 193(18):4634-42. PubMed ID: 21764940
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Conformational Changes and Membrane Interaction of the Bacterial Phospholipase, ExoU: Characterization by Site-Directed Spin Labeling.
    Feix JB; Kohn S; Tessmer MH; Anderson DM; Frank DW
    Cell Biochem Biophys; 2019 Mar; 77(1):79-87. PubMed ID: 30047043
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ubiquitin and ubiquitin-modified proteins activate the Pseudomonas aeruginosa T3SS cytotoxin, ExoU.
    Anderson DM; Schmalzer KM; Sato H; Casey M; Terhune SS; Haas AL; Feix JB; Frank DW
    Mol Microbiol; 2011 Dec; 82(6):1454-67. PubMed ID: 22040088
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cooperative Substrate-Cofactor Interactions and Membrane Localization of the Bacterial Phospholipase A
    Tessmer MH; Anderson DM; Buchaklian A; Frank DW; Feix JB
    J Biol Chem; 2017 Feb; 292(8):3411-3419. PubMed ID: 28069812
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Presence of the exoU gene of Pseudomonas aeruginosa is correlated with cytotoxicity in MDCK cells but not with colonization in BALB/c mice.
    Lin HH; Huang SP; Teng HC; Ji DD; Chen YS; Chen YL
    J Clin Microbiol; 2006 Dec; 44(12):4596-7. PubMed ID: 17050810
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of type III secretion system virulence among fluoroquinolone-susceptible and -resistant clinical isolates of Pseudomonas aeruginosa.
    Wong-Beringer A; Wiener-Kronish J; Lynch S; Flanagan J
    Clin Microbiol Infect; 2008 Apr; 14(4):330-6. PubMed ID: 18190571
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The bacterial toxin ExoU requires a host trafficking chaperone for transportation and to induce necrosis.
    Deruelle V; Bouillot S; Job V; Taillebourg E; Fauvarque MO; Attrée I; Huber P
    Nat Commun; 2021 Jun; 12(1):4024. PubMed ID: 34188051
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ExoU-induced vascular hyperpermeability and platelet activation in the course of experimental Pseudomonas aeruginosa pneumosepsis.
    Machado GB; de Assis MC; Leão R; Saliba AM; Silva MC; Suassuna JH; de Oliveira AV; Plotkowski MC
    Shock; 2010 Mar; 33(3):315-21. PubMed ID: 19543153
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relative contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to virulence in the lung.
    Shaver CM; Hauser AR
    Infect Immun; 2004 Dec; 72(12):6969-77. PubMed ID: 15557619
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genotypic and phenotypic analysis of type III secretion system in a cohort of Pseudomonas aeruginosa bacteremia isolates: evidence for a possible association between O serotypes and exo genes.
    Berthelot P; Attree I; Plésiat P; Chabert J; de Bentzmann S; Pozzetto B; Grattard F;
    J Infect Dis; 2003 Aug; 188(4):512-8. PubMed ID: 12898437
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of a ubiquitin-binding interface using Rosetta and DEER.
    Tessmer MH; Anderson DM; Pickrum AM; Riegert MO; Moretti R; Meiler J; Feix JB; Frank DW
    Proc Natl Acad Sci U S A; 2018 Jan; 115(3):525-530. PubMed ID: 29295930
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The human pathogen Pseudomonas aeruginosa utilizes conserved virulence pathways to infect the social amoeba Dictyostelium discoideum.
    Pukatzki S; Kessin RH; Mekalanos JJ
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):3159-64. PubMed ID: 11867744
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence of type III secretion protein exoenzymes and antimicrobial susceptibility patterns from bloodstream isolates of patients with Pseudomonas aeruginosa bacteremia.
    Garey KW; Vo QP; Larocco MT; Gentry LO; Tam VH
    J Chemother; 2008 Dec; 20(6):714-20. PubMed ID: 19129069
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activation of ExoU phospholipase activity requires specific C-terminal regions.
    Schmalzer KM; Benson MA; Frank DW
    J Bacteriol; 2010 Apr; 192(7):1801-12. PubMed ID: 20097856
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Eukaryotic localization, activation and ubiquitinylation of a bacterial type III secreted toxin.
    Stirling FR; Cuzick A; Kelly SM; Oxley D; Evans TJ
    Cell Microbiol; 2006 Aug; 8(8):1294-309. PubMed ID: 16882033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.